Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

The inpatient burden and comorbidities of pyoderma gangrenosum in adults in the United States. Arch Dermatol Res 2021 May;313(4):245-253

Date

07/06/2020

Pubmed ID

32620994

DOI

10.1007/s00403-020-02098-7

Scopus ID

2-s2.0-85087506867 (requires institutional sign-in at Scopus site)   6 Citations

Abstract

Hospital admission is often necessary for management of pyoderma gangrenosum (PG), including wound care and pain control. No large-scale controlled studies examined the burden of hospitalization for PG. The objective of this study is to determine the prevalence, predictors, outcomes, and costs of hospitalization for PG in United States adults. Data were analyzed from the 2002 to 2012 National Inpatient Sample, including a 20% representative sample of United States hospitalizations. The prevalence of hospitalization for PG increased between 2002 and 2012. Primary admission for PG was associated with age 40-59 years, female sex, black race/ethnicity, second-quartile household income, public or no insurance, and multiple chronic conditions. PG admissions were more likely at teaching and medium or large hospitals. Geometric-mean length and cost of hospitalization were higher in inpatients with vs. without a primary diagnosis of PG. The majority of inpatients with PG were classified with minor (64.4%) or moderate (25.7%) likelihood of dying, but moderate (52.5%) and major (28.7%) loss of function. PG was associated with numerous other health disorders. The limitation of this study is the lack of data on PG treatment. This study demonstrated a substantial and increasing inpatient burden of PG in the United States, with considerable disability and mortality risk, multiple comorbid health disorders, and costs.

Author List

Narla S, Silverberg JI

Author

Shanthi Narla MD Assistant Professor in the Dermatology department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Adolescent
Adult
Aged
Aged, 80 and over
Comorbidity
Cost of Illness
Female
Health Care Costs
Humans
Length of Stay
Male
Middle Aged
Mortality
Patient Admission
Prevalence
Pyoderma Gangrenosum
Retrospective Studies
United States
Young Adult